In vitro cytotoxicity of benzopyranone derivatives with basic side chain against human lung cell lines

Anticancer Research

Volumn 30, Issue 11, 2010, Pages 4613-4617

  Musa, Musiliyu A ^a   Badisa, Veera L D ^a   Latinwo, Lekan M ^a   Waryoba, Caroline ^a   Ugochukwu, Ngozi ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Basic amino side chain; Benzopyranone derivatives; Cell cycle; Cell viability; Coumarin

Indexed keywords

BENZOPYRAN DERIVATIVE; BENZOPYRANONE DERIVATIVE; COUMARIN DERIVATIVE; CRYSTAL VIOLET; DIETHYLAMINOETHOXY; DIMETHYLAMINOETHOXY; MORPHOLINOETHOXY; PIPERIDINYLETHOXY; PYRROLIDINYLETHOXYL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING ASSAY; CELL CYCLE; CELL CYCLE PROGRESSION; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LD 50; LUNG ALVEOLUS CELL; PRIORITY JOURNAL;

CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; COUMARINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; LUNG; LUNG NEOPLASMS;

EID: 78650232471     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Nofal ZM, El-Zahar MI and AbdEl-Karim SS: Novel Coumarin Derivatives with expected biological activity. Molecules 5: 99-113, 2000.
2. Takeuchi Y, Xie L, Cosentino LM and Lee KH: Anti-AIDS agents-XXVIII. synthesis and anti-HIV activity of methoxy substituted 3′, 4′-di-O-(-)-camphanoyl-(+)-cis khellactone (DCK) analogues. Bioorg Med Chem Lett 7: 2573-2578, 1997.
3. Madari H, Panda D, Wilson L and Jacobs RS: Dicoumarol: A unique microtubule-stabilizing natural product that is synergistic with Taxol. Cancer Res 63(6): 1214-1220, 2003.
4. Musiciki B, Periers AM, Laurin P, Ferroud D, Benedetti Y, Lachaud S, Chatreaux F, Haesslein JL, LLtis A, Pierre C, Khider J, Tessol N, Airault M, Demassey J, Dupuis-Hamelin C, Lassaigne P, Bonnefoy A, Vicat P and Klich M: Improved antibacterial activities of coumarin antibiotics bearing 5′,5′-dialkylnoviose: biological activity of RU 79115. Bioorg Med Chem Lett 10: 1695-1699, 2000.
5. Abd Allah OA: Synthesis and biological studies of some benzopyran. Farmaco 55(9-10): 641-649, 2000.
6. Lacy A and O'Kennedy R: Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr Pharm Des 10(30): 3797-3811, 2004.
7. Stanchev S, Momekov G, Jensen F and Manolov I: Synthesis, computational study and cytotoxic activity of new 4-hydroxycoumarin derivatives. Eur J Med Chem 43(4): 694-706, 2008.
8. Thornes RD, Daly L, Lynch G, Breslin B, Browne H, Browne HY, Corrigan T, Daly P, Edwards G, Gaffney E, Henley J, Healy F, Keane F, Lennon F, McMurray N, O'Loughlin S, Shine M and Tanner A: Treatment with coumarin to prevent or delay recurrence of malignant melanoma. J Cancer Res Clin Oncol 120 Suppl: S32-34, 1994.
9. Mohler JL, Gomella LG, Crawford ED, Glode LM, Zippe CD, Fair WR and Marshall ME: Phase II evaluation of coumarin (1,2-benzopyrone) in metastatic prostatic carcinoma. Prostate 20(2): 123-131, 1992.
10. Stanchev S, Momekov G, Jensen F and Manolov I: Synthesis, computational study and cytotoxic activity of new 4-hydroxycoumarin derivatives. Eur J Med Chem 43(4): 694-706, 2008.
11. Egan D, James P, Cooke D and O'Kennedy R: Studies on the cytostatic and cytotoxic effects and mode of action of 8-nitro-7-hydroxycoumarin. Cancer Lett 118(2): 201-211, 1997.
12. Lopez-Gonzalez JS, Prado-Garcia H, Aguilar-Cazares D, Molina-Guarneros JA, Morales-Fuentes J and Mandoki JJ: Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines. Lung Cancer 43(3): 275-283, 2004.
13. Goel A, Prasad AK, Parmar VS, Ghosh B and Saini N: 7,8-Dihydroxy-4- methylcoumarin induces apoptosis of human lung adenocarcinoma cells by ROS-independent mitochondrial pathway through partial inhibition of ERK/MAPK signaling. FEBS Lett 581(13): 2447-2454, 2007.
14. Kahn J, Preis P, Waldman F and Tseng A, Jr: Coumarin modulates the cell-cycle progression of an MTV-EJras cell line. J Cancer Res Clin Oncol 120 Suppl: S19-22, 1994.
15. Kim YW, Mobley JA and Brueggemeier RW: Synthesis and estrogen receptor binding affinities of 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-ones containing a basic side chain. Bioorg Med Chem Lett 13(8): 1475-1478, 2003.
16. Sharma AP, Saeed A, Durani S and Kapil RS: Structure-activity relationship of antiestrogens. Effect of the side chain and its position on the activity of 2,3-diaryl-2H-1-benzopyrans. J Med Chem 33(12): 3216-3222, 1990.
17. Jain N, Xu J, Kanojia RM, Du F, Jian-Zhong G, Pacia E, Lai MT, Musto A, Allan G, Reuman M, Li X, Hahn DW, Cousineau M, Peng, S, Ritchie D, Russell R, Lundeen S and Sui Z: Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms. J Med Chem 52(23): 7544-7569, 2009.
18. Wallace OB, Bryant HU, Shetler PK, Adrian MD and Geiser AG: Benzothiophene and naphthalene derived constrained SERMs. Bioorg Med Chem Lett 14(20): 5103-5106, 2004.
19. Croxtall JD, Emmas C, White JO, Choudhary Q and Flower RJ: Tamoxifen inhibits growth of oestrogen receptor-negative A549 cells. Biochem Pharmacol 47(2): 197-202, 1994.
20. Caltagirone S, Ranelletti FO, Rinelli A, Maggiano N, Colasante A, Musiani P, Aiello FB and Piantelli M: Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small cell lung cancer. Am J Respir Cell Mol Biol 17(1): 51-59, 1997.
21. Badisa RB, Tzakou O, Couladis M and Pilarinou E: Cytotoxic activities of some Greek Labiatae herbs. Phytother Res 17: 472-476, 2003.
22. Badisa RB, Darling-Reed SF, Joseph P, Cooperwood S, Latinwo LM and Goodman CB: Selective cytotoxic activities of two novel synthetic drugs on human breast carcinoma MCF-7 cells. Anticancer Res 29: 2993-2996, 2009.
23. Koch A, Tamez P, Pezzuto J and Soejarto D: Evaluation of plants used for antimalarial treatment by the Massai of Kenya. J Efhnopharmacol 101: 95-99, 2005
24. Ipsen J and Feigl P: Bancroft's Introduction to Biostatistics, 2nd edition. Harper and Row, New York, p. 164, 1970.